{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:20Z","timestamp":1777370900909,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Single-nucleotide polymorphisms (SNPs) in the <jats:italic>CRP<\/jats:italic> gene are implicated in the regulation of the constitutional C-reactive protein (CRP) expression and its response to proinflammatory stimuli. Previous reports suggest that these effects may have an impact on clinical decision-making tools based on CRP, such as the Disease Activity Score in 28 joints (DAS28). We aimed to investigate the possible association between seven <jats:italic>CRP<\/jats:italic> SNPs, their haplotypes and the serum levels of CRP, as well as DAS28 scores, in two cohorts of untreated active early rheumatoid arthritis (RA) patients followed during their initial treatment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Overall, 315 patients with RA from two randomized controlled trials (the CIMESTRA and OPERA trials) who were na\u00efve to disease-modifying antirheumatic drugs and steroids with disease durations less than 6 months were included. Seven <jats:italic>CRP<\/jats:italic> SNPs were investigated: rs11265257, rs1130864, rs1205, rs1800947, rs2808632, rs3093077 and rs876538. The genotype and haplotype associations with CRP and DAS28 levels were evaluated using linear regression analysis adjusted for age, sex and treatment.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>The minor allele of rs1205 C &gt; T was associated with decreased CRP levels at baseline (<jats:italic>P<\/jats:italic> = 0.03), with the TT genotype having a 50% reduction in CRP from 16.7 to 8.4 mg\/L (<jats:italic>P<\/jats:italic> = 0.005) compared to homozygosity of the major allele, but no association was observed at year 1 (<jats:italic>P<\/jats:italic> = 0.38). The common H2 haplotype, characterized by the T allele of rs1205, was associated with a 26% reduction in CRP at baseline (<jats:italic>P<\/jats:italic> = 0.043), although no effect was observed at year 1 (<jats:italic>P<\/jats:italic> = 0.466). No other SNP or haplotype was associated with CRP at baseline or at year 1 (<jats:italic>P<\/jats:italic> \u22650.09). We observed no associations between SNPs or haplotypes and DAS28 scores at baseline or at year 1 (<jats:italic>P<\/jats:italic> \u22650.10).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p><jats:italic>CRP<\/jats:italic> genotype and haplotype were only marginally associated with serum CRP levels and had no association with the DAS28 score. This study shows that DAS28, the core parameter for inflammatory activity in RA, can be used for clinical decision-making without adjustment for <jats:italic>CRP<\/jats:italic> gene variants.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Trial registration<\/jats:title>\n                        <jats:p>The OPERA study is registered at Clinicaltrials.gov (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/show\/NCT00660647\">NCT00660647<\/jats:ext-link>). The CIMESTRA study is not listed in a clinical trials registry, because patients were included between October 1999 and October 2002.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0475-3","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T18:46:14Z","timestamp":1414608374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Christian Gytz","family":"Ammitzb\u00f8ll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi","family":"Steffensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"B\u00f8gsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"H\u00f8rslev-Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merete L","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Junker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia S","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"P\u00f8denphant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torkell","family":"Ellingsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Stengaard-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"475_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillett","year":"1930","unstructured":"Tillett WS, Francis T: Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930, 52: 561-571. 10.1084\/jem.52.4.561.","journal-title":"J Exp Med"},{"key":"475_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1172\/JCI18921C1","volume":"112","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812. A published erratum appears in. J Clin Invest. 2003, 112: 299-10.1172\/JCI18921C1.","journal-title":"J Clin Invest"},{"key":"475_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","volume":"28","author":"B Bottazzi","year":"2010","unstructured":"Bottazzi B, Doni A, Garlanda C, Mantovani A: An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010, 28: 157-183. 10.1146\/annurev-immunol-030409-101305.","journal-title":"Annu Rev Immunol"},{"key":"475_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/obr.12003","volume":"14","author":"J Choi","year":"2013","unstructured":"Choi J, Joseph L, Pilote L: Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013, 14: 232-244. 10.1111\/obr.12003.","journal-title":"Obes Rev"},{"key":"475_CR5","doi-asserted-by":"publisher","first-page":"891","DOI":"10.7326\/0003-4819-138-11-200306030-00010","volume":"138","author":"LA Bazzano","year":"2003","unstructured":"Bazzano LA, He J, Muntner P, Vupputuri S, Whelton PK: Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003, 138: 891-897. 10.7326\/0003-4819-138-11-200306030-00010.","journal-title":"Ann Intern Med"},{"key":"475_CR6","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jc.2008-2406","volume":"94","author":"A Khera","year":"2009","unstructured":"Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, de Lemos JA: Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab. 2009, 94: 3251-3258. 10.1210\/jc.2008-2406.","journal-title":"J Clin Endocrinol Metab"},{"key":"475_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","volume":"123","author":"A Dehghan","year":"2011","unstructured":"Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P, Baumert J, Strachan DP, Fuchsberger C, Vitart V, Wilson JF, Par\u00e9 G, Naitza S, Rudock ME, Surakka I, de Geus EJ, Alizadeh BZ, Guralnik J, Shuldiner A, Tanaka T, Zee RY, Schnabel RB, Nambi V, Kavousi M, Ripatti S, Nauck M: Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011, 123: 731-738. 10.1161\/CIRCULATIONAHA.110.948570.","journal-title":"Circulation"},{"key":"475_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.atherosclerosis.2004.07.033","volume":"178","author":"HJ Suk","year":"2005","unstructured":"Suk HJ, Ridker PM, Cook NR, Zee RY: Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis. 2005, 178: 139-145. 10.1016\/j.atherosclerosis.2004.07.033.","journal-title":"Atherosclerosis"},{"key":"475_CR9","doi-asserted-by":"publisher","first-page":"H2752","DOI":"10.1152\/ajpheart.01164.2005","volume":"291","author":"Q Wang","year":"2006","unstructured":"Wang Q, Hunt SC, Xu Q, Chen YE, Province MA, Eckfeldt JH, Pankow JS, Song Q: Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol. 2006, 291: H2752-H2757. 10.1152\/ajpheart.01164.2005.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"475_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0021-9150(00)00586-4","volume":"154","author":"JS Pankow","year":"2001","unstructured":"Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, Tracy RP: Familial and genetic determinants of systemic markers of inflammation: the NHLBI Family Heart Study. Atherosclerosis. 2001, 154: 681-689. 10.1016\/S0021-9150(00)00586-4.","journal-title":"Atherosclerosis"},{"key":"475_CR11","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3899\/jrheum.080262","volume":"35","author":"PB Shih","year":"2008","unstructured":"Shih PB, Manzi S, Shaw P, Kenney M, Kao AH, Bontempo F, Barmada MM, Kammerer C, Kamboh MI: Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. J Rheumatol. 2008, 35: 2171-2178. 10.3899\/jrheum.080262.","journal-title":"J Rheumatol"},{"key":"475_CR12","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/eurheartj\/ehl018","volume":"27","author":"I Kardys","year":"2006","unstructured":"Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC: C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J. 2006, 27: 1331-1337. 10.1093\/eurheartj\/ehl018.","journal-title":"Eur Heart J"},{"key":"475_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2350-10-38","volume":"10","author":"TE Perry","year":"2009","unstructured":"Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, Body SC, Shernan SK: C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet. 2009, 10: 38-10.1186\/1471-2350-10-38.","journal-title":"BMC Med Genet"},{"key":"475_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2004.10.036","volume":"179","author":"F D\u2019Aiuto","year":"2005","unstructured":"D\u2019Aiuto F, Casas JP, Shah T, Humphries SE, Hingorani AD, Tonetti MS: C-reactive protein (+1444C > T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis. 2005, 179: 413-417. 10.1016\/j.atherosclerosis.2004.10.036.","journal-title":"Atherosclerosis"},{"key":"475_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.blre.2012.12.001","volume":"27","author":"E Grad","year":"2013","unstructured":"Grad E, Danenberg HD: C-reactive protein and atherothrombosis: cause or effect?. Blood Rev. 2013, 27: 23-29. 10.1016\/j.blre.2012.12.001.","journal-title":"Blood Rev"},{"key":"475_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nrrheum.2011.37","volume":"7","author":"B Rhodes","year":"2011","unstructured":"Rhodes B, F\u00fcrnrohr BG, Vyse TJ: C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011, 7: 282-289. 10.1038\/nrrheum.2011.37.","journal-title":"Nat Rev Rheumatol"},{"key":"475_CR17","doi-asserted-by":"publisher","first-page":"R214","DOI":"10.1186\/ar4052","volume":"14","author":"D Plant","year":"2012","unstructured":"Plant D, Ibrahim I, Lunt M, Eyre S, Flynn E, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Barton A: Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Res Ther. 2012, 14: R214-10.1186\/ar4052.","journal-title":"Arthritis Res Ther"},{"key":"475_CR18","doi-asserted-by":"publisher","first-page":"e1000341","DOI":"10.1371\/journal.pmed.1000341","volume":"7","author":"B Rhodes","year":"2010","unstructured":"Rhodes B, Merriman ME, Harrison A, Nissen MJ, Smith M, Stamp L, Steer S, Merriman TR, Vyse TJ: A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med. 2010, 7: e1000341-10.1371\/journal.pmed.1000341.","journal-title":"PLoS Med"},{"key":"475_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/annrheumdis-2012-202735","volume":"73","author":"K H\u00f8rslev-Petersen","year":"2014","unstructured":"H\u00f8rslev-Petersen K, Hetland ML, Junker P, P\u00f8denphant J, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Horn HC, Ammitzb\u00f8ll CG, J\u00f8rgensen A, Krintel SB, Raun J, Johansen JS, \u00d8stergaard M, Stengaard-Pedersen K: Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Ann Rheum Dis. 2014, 73: 654-661. 10.1136\/annrheumdis-2012-202735.","journal-title":"Ann Rheum Dis"},{"key":"475_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/ard.2007.076307","volume":"67","author":"ML Hetland","year":"2008","unstructured":"Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skj\u00f8dt H, Lauridsen UB, Ellingsen T, Hansen GV, Lindegaard H, Vestergaard A, Jurik AG, \u00d8stergaard M, H\u00f8rslev-Petersen K: Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis. 2008, 67: 815-822. 10.1136\/ard.2007.076307.","journal-title":"Ann Rheum Dis"},{"key":"475_CR21","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/art.21796","volume":"54","author":"ML Hetland","year":"2006","unstructured":"Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skj\u00f8dt H, Pedersen JK, Lauridsen UB, Svendsen A, Tarp U, P\u00f8denphant J, Hansen G, Lindegaard H, de Carvalho A, \u00d8stergaard M, H\u00f8rslev-Petersen K: Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum. 2006, 54: 1401-1409. 10.1002\/art.21796.","journal-title":"Arthritis Rheum"},{"key":"475_CR22","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1136\/annrheumdis-2011-200632corr1","volume":"71","author":"ML Hetland","year":"2012","unstructured":"Hetland ML, \u00d8stergaard M, Ejbjerg B, Jacobsen S, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Svendsen A, Pedersen JK, Skj\u00f8dt H, Ellingsen T, Lindegaard H, P\u00f8denphant J, H\u00f8rslev-Petersen K:Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP.Ann Rheum Dis 2012, 71:851-856. A published erratum appears in. Ann Rheum Dis. 2012, 71: 1918-10.1136\/ard.2008.099010corr2.","journal-title":"Ann Rheum Dis"},{"key":"475_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"475_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010, 69: 631-637. 10.1136\/ard.2009.123919.","journal-title":"Ann Rheum Dis"},{"key":"475_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.gene.6364459","volume":"9","author":"B Rhodes","year":"2008","unstructured":"Rhodes B, Wong A, Navarra SV, Villamin C, Vyse TJ: Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Genes Immun. 2008, 9: 153-160. 10.1038\/sj.gene.6364459.","journal-title":"Genes Immun"},{"key":"475_CR26","doi-asserted-by":"publisher","first-page":"e50585","DOI":"10.1371\/journal.pone.0050585","volume":"7","author":"CG Ammitzb\u00f8ll","year":"2012","unstructured":"Ammitzb\u00f8ll CG, Kj\u00e6r TR, Steffensen R, Stengaard-Pedersen K, Nielsen HJ, Thiel S, B\u00f8gsted M, Jensenius JC: Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin. PLoS One. 2012, 7: e50585-10.1371\/journal.pone.0050585.","journal-title":"PLoS One"},{"key":"475_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1515\/CCLM.2009.246","volume":"47","author":"E Zecca","year":"2009","unstructured":"Zecca E, Barone G, Corsello M, Romagnoli C, Tiberi E, Tirone C, Vento G: Reliability of two different bedside assays for C-reactive protein in newborn infants. Clin Chem Lab Med. 2009, 47: 1081-1084. 10.1515\/CCLM.2009.246.","journal-title":"Clin Chem Lab Med"},{"key":"475_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/ard.2008.088245","volume":"68","author":"ML Hetland","year":"2009","unstructured":"Hetland ML, Ejbjerg B, H\u00f8rslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skj\u00f8dt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vall\u00f8 J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M: MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis: results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis. 2009, 68: 384-390. 10.1136\/ard.2008.088245.","journal-title":"Ann Rheum Dis"},{"key":"475_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093\/bioinformatics\/bth457.","journal-title":"Bioinformatics"},{"key":"475_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1086\/338688","volume":"70","author":"DJ Schaid","year":"2002","unstructured":"Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002, 70: 425-434. 10.1086\/338688.","journal-title":"Am J Hum Genet"},{"key":"475_CR31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1469-1809.2006.00272.x","volume":"70","author":"DJ Suk","year":"2006","unstructured":"Suk DJ, Chasman DI, Cannon CP, Miller DT, Zee RY, Kozlowski P, Kwiatkowski DJ, Ridker PM: Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet. 2006, 70: 705-716. 10.1111\/j.1469-1809.2006.00272.x.","journal-title":"Ann Hum Genet"},{"key":"475_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1529-8817.2005.00210.x","volume":"69","author":"DT Miller","year":"2005","unstructured":"Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ: Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet. 2005, 69: 623-638. 10.1111\/j.1529-8817.2005.00210.x.","journal-title":"Ann Hum Genet"},{"key":"475_CR33","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1001\/jama.296.22.2703","volume":"296","author":"LA Lange","year":"2006","unstructured":"Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP: Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA. 2006, 296: 2703-2711. 10.1001\/jama.296.22.2703.","journal-title":"JAMA"},{"key":"475_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/ard.62.7.624","volume":"62","author":"J Fransen","year":"2003","unstructured":"Fransen J, Welsing PMJ, de Keijzer RMH, van Riel PLCM: Development and validation of the DAS28 using CRP [Abstract SP0029]. Ann Rheum Dis. 2003, 62: 10-10.1136\/ard.62.7.624.","journal-title":"Ann Rheum Dis"},{"key":"475_CR35","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1021\/bi052646f","volume":"45","author":"LT Roumenina","year":"2006","unstructured":"Roumenina LT, Ruseva MM, Zlatarova A, Ghai R, Kolev M, Olova N, Gadjeva M, Agrawal A, Bottazzi B, Mantovani A, Reid KB, Kishore U, Kojouharova MS: Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry. 2006, 45: 4093-4104. 10.1021\/bi052646f.","journal-title":"Biochemistry"},{"key":"475_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/07853890701477546","volume":"39","author":"M Okroj","year":"2007","unstructured":"Okroj M, Heineg\u00e5rd D, Holmdahl R, Blom AM: Rheumatoid arthritis and the complement system. Ann Med. 2007, 39: 517-530. 10.1080\/07853890701477546.","journal-title":"Ann Med"},{"key":"475_CR37","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/art.21204","volume":"52","author":"NJ Goodson","year":"2005","unstructured":"Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ: Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum. 2005, 52: 2293-2299. 10.1002\/art.21204.","journal-title":"Arthritis Rheum"},{"key":"475_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/annrheumdis-2012-201931","volume":"72","author":"R Knevel","year":"2013","unstructured":"Knevel R, van Nies JA, le Cessie S, Huizinga TW, Brouwer E, van der Helm-van Mil AH: Evaluation of the contribution of cumulative levels of inflammation to the variance in joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2013, 72: 307-308. 10.1136\/annrheumdis-2012-201931.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0475-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0475-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:25:16Z","timestamp":1728923116000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0475-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["475"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0475-3","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]},"assertion":[{"value":"21 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"475"}}